GG wrote the plant-fungus section
April 1, 2026: More Lawsuits Join Vision Loss MDL for GLP-1 Drugs, Like Ozempic As of April 1, 2026, there are 73 pending lawsuits in the centralized litigation for people alleging NAION from GLP-1 drugs, including Ozempic
doi: 10.1155/2012/302537 107 AdemoluEOzbeyNErbilYTanrikuluSBarbarosUYanikBTet al
Description Buy BPC-157 10mg Exclusively At The Peptide Labs | Buy Peptides Canada BPC-157 10mg: 7 Best Amazing Secrets of the Ultimate Tissue Repair Peptide BPC-157 is a highly purified, synthetic research peptide derived from a naturally occurring fifteen-amino-acid fragment of a body protection compound originally discovered in human gastric juice
For upcoming studies, it would be important to identify any potential high-risk subgroups as well as assess whether the elevated risk of NAION is a drug class effect or a specific finding for subcutaneously administered semaglutide. 12.02.24 MDL cases continued to grow in December The GLP-1 MDL continued to grow, bringing the total number of cases in the docket to 1,300